Bath & Body Works (BBWI) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Bath & Body Works (BBWI) reported Q1 revenue of $1.42 billion, a 2.9% increase year-over-year, and EPS of $0.49, up from $0.38 in the prior year. Revenue was in line with consensus estimates, while EPS beat estimates by 4.26%. Key metrics showed U.S. and Canada store sales exceeding estimates at $1.11 billion, a 4.2% increase year-over-year, while international sales and direct sales in the U.S. and Canada were below estimates.

Analysis

Bath & Body Works reported Q1 revenue of $1.42 billion, a 2.9% year-over-year increase, which was marginally below consensus estimates by -0.02%. However, earnings per share (EPS) of $0.49 significantly surpassed the prior year's $0.38 and beat analyst expectations by 4.26%, against a consensus of $0.47. Key metric analysis reveals a nuanced picture: U.S. and Canada store-based net sales were robust at $1.11 billion, exceeding the $1.09 billion estimate and growing 4.2% year-over-year. Conversely, direct channel net sales in the U.S. and Canada underperformed, declining 4.2% year-over-year to $250 million, below the $265.49 million estimate. International net sales, while up 10.3% year-over-year to $64 million, also fell short of the $65.31 million forecast. Store count figures were slightly below estimates, with total company-operated stores at 1,900 (versus 1,903 estimated) and total partner-operated international stores at 524 (versus 541 estimated). The company's stock has underperformed the S&P 500 composite over the past month, returning -0.1% compared to the index's +6.7% gain, and currently holds a Zacks Rank #3 (Hold), indicating expectations of near-term in-line market performance.

Key Decisions for Investors

• Investors should closely monitor the company's strategies to address the decline in U.S. and Canada direct channel sales and to improve international sales performance against analyst expectations.
• Given the mixed operational results, with strong domestic store performance offset by softness in direct sales and international estimates, maintaining a neutral stance, in line with the Zacks #3 (Hold) rank, may be warranted pending clearer signs of broad-based growth.
• Consider the recent stock underperformance relative to the broader market as indicative of investor concerns over these mixed signals, and watch for catalysts that could improve direct channel traction and international partner productivity.